| Autor: |
Larocca CA; Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts., Fay CJ; Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts., Hirner JP; Department of Dermatology, University of Missouri Health Care, Columbia., Meyerhardt JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Dewan AK; Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee., LeBoeuf NR; Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts. |
